GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BioLargo Inc (OTCPK:BLGO) » Definitions » Cyclically Adjusted PS Ratio

BioLargo (BioLargo) Cyclically Adjusted PS Ratio : 14.62 (As of May. 31, 2024)


View and export this data going back to 1991. Start your Free Trial

What is BioLargo Cyclically Adjusted PS Ratio?

As of today (2024-05-31), BioLargo's current share price is $0.29235. BioLargo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.02. BioLargo's Cyclically Adjusted PS Ratio for today is 14.62.

The historical rank and industry rank for BioLargo's Cyclically Adjusted PS Ratio or its related term are showing as below:

BLGO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 7.92   Med: 22   Max: 83
Current: 16.66

During the past years, BioLargo's highest Cyclically Adjusted PS Ratio was 83.00. The lowest was 7.92. And the median was 22.00.

BLGO's Cyclically Adjusted PS Ratio is ranked worse than
97.94% of 1214 companies
in the Chemicals industry
Industry Median: 1.215 vs BLGO: 16.66

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BioLargo's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.016. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.02 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


BioLargo Cyclically Adjusted PS Ratio Historical Data

The historical data trend for BioLargo's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLargo Cyclically Adjusted PS Ratio Chart

BioLargo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.60 13.05 20.98 15.39 9.99

BioLargo Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.44 12.14 10.71 9.99 19.14

Competitive Comparison of BioLargo's Cyclically Adjusted PS Ratio

For the Chemicals subindustry, BioLargo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLargo's Cyclically Adjusted PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BioLargo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BioLargo's Cyclically Adjusted PS Ratio falls into.



BioLargo Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

BioLargo's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.29235/0.02
=14.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLargo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, BioLargo's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.016/131.7762*131.7762
=0.016

Current CPI (Mar. 2024) = 131.7762.

BioLargo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.001 99.070 0.001
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.001 100.392 0.001
201512 0.001 99.792 0.001
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.002 101.861 0.003
201612 0.001 101.863 0.001
201703 0.000 102.862 0.000
201706 0.001 103.349 0.001
201709 0.002 104.136 0.003
201712 0.002 104.011 0.003
201803 0.003 105.290 0.004
201806 0.003 106.317 0.004
201809 0.002 106.507 0.002
201812 0.004 105.998 0.005
201903 0.003 107.251 0.004
201906 0.003 108.070 0.004
201909 0.003 108.329 0.004
201912 0.003 108.420 0.004
202003 0.003 108.902 0.004
202006 0.002 108.767 0.002
202009 0.003 109.815 0.004
202012 0.004 109.897 0.005
202103 0.002 111.754 0.002
202106 0.002 114.631 0.002
202109 0.003 115.734 0.003
202112 0.003 117.630 0.003
202203 0.004 121.301 0.004
202206 0.005 125.017 0.005
202209 0.006 125.227 0.006
202212 0.008 125.222 0.008
202303 0.013 127.348 0.013
202306 0.005 128.729 0.005
202309 0.009 129.860 0.009
202312 0.015 129.419 0.015
202403 0.016 131.776 0.016

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioLargo  (OTCPK:BLGO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


BioLargo Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of BioLargo's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLargo (BioLargo) Business Description

Industry
Traded in Other Exchanges
N/A
Address
14921 Chestnut Street, Westminster, CA, USA, 92683
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, advanced water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. BioLargo invents or acquires novel technologies and develops them to maturity through its operating subsidiaries. It monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation, and/or the sale of the IP. The firm's technologies are commercially available and are advancing as disrupters in their respective markets.
Executives
Linda Park director 14921 CHESTNUT STREET, WESTMINSTER CA 92683
Christina Elaine Bray director PO BOX 234, FREDERICK CO 80530
Jack B. Strommen director 7108 31ST AVENUE N., MINNEAPOLIS MN 55427
Roberts Kent Charles Ii director 1146 OXFORD ROAD, SAN MARINO CA 91108
John S. Runyan director 30001 HILLSIDE TERRACE, SAN JUAN CAPISTRANO CA 92675
Dennis E Marshall director 3500 W. GARRY AVENUE, SANTA ANA CA 92705
Dennis P Calvert director, 10 percent owner, officer: Chief Executive Officer 3500 GARRY AVE, SANTA ANA CA 92704
New Millennium Capital Partners, Llc 10 percent owner 16333 PHOEBE AVENUE, LA MIRADA CA 90638
Charles K Dargan officer: Chief Financial Officer 8055 W. MANCHESTER AVE., SUITE 405, PLAYA DEL REY CA 90293
Joseph L Provenzano director, officer: Corporate Secretary 3500 W. GARRY AVENUE, SANTA ANA CA 92704
Iowc Technologies, Inc. 10 percent owner 2603 MAIN STREET, SUITE 1155, IRVINE CA 92614
Kenneth Reay Code 10 percent owner 16150 HERON AVENUE, LA MIRADA CA 90638
Gary Adrian Cox director 3500 W. GARRY AVENUE, SANTA ANA CA 92705
Steven V Harrison director
Eduardo Ruiz director, 10 percent owner